Jane Street Group, LLC Intra Cellular Therapies, Inc. Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 267,102 shares of ITCI stock, worth $34.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

267,102

Previous 294,860 9.41%

Holding current value

$34.3 Million

Previous $21.6 Million 3.47%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$71.19 - $91.57 $1.98 Million - $2.54 Million	-27,758 Reduced 9.41%	267,102 $22.3 Million
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $12.7 Million - $15.1 Million	-186,345 Reduced 38.72%	294,860 $21.6 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $27.8 Million - $34.2 Million	428,607 Added 814.87%	481,205 $33 Million
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $7.36 Million - $8.65 Million	-114,318 Reduced 68.49%	52,598 $3.64 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $6.86 Million - $10.9 Million	148,015 Added 783.11%	166,916 $12 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $7.28 Million - $8.96 Million	-139,850 Reduced 88.09%	18,901 $984,000
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $2.79 Million - $3.4 Million	51,112 Added 47.48%	158,751 $10.1 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.53 Million - $1.99 Million	34,913 Added 48.01%	107,639 $5.83 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $958,698 - $1.18 Million	-21,754 Reduced 23.02%	72,726 $3.85 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $2.89 Million - $4.06 Million	67,729 Added 253.18%	94,480 $4.4 Million
Q2 2022 Aug 16, 2022	SELL	$43.0 - $65.64 $232,157 - $354,390	-5,399 Reduced 16.79%	26,751 $1.53 Million
Q1 2022 May 17, 2022	SELL	$38.74 - $62.09 $322,123 - $516,278	-8,315 Reduced 20.55%	32,150 $1.97 Million
Q4 2021 Feb 15, 2022	BUY	$35.2 - $53.42 $835,366 - $1.27 Million	23,732 Added 141.83%	40,465 $2.12 Million
Q3 2021 Nov 16, 2021	BUY	$28.72 - $42.49 $320,974 - $474,868	11,176 Added 201.12%	16,733 $624,000
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $188,486 - $286,268	-6,433 Reduced 53.65%	5,557 $227,000
Q1 2021 May 18, 2021	SELL	$30.8 - $39.51 $2.11 Million - $2.71 Million	-68,563 Reduced 85.12%	11,990 $407,000
Q4 2020 Feb 17, 2021	BUY	$23.34 - $32.22 $268,316 - $370,401	11,496 Added 16.65%	80,553 $2.56 Million
Q3 2020 Nov 17, 2020	SELL	$17.61 - $31.86 $2.8 Million - $5.07 Million	-159,174 Reduced 69.74%	69,057 $1.77 Million
Q2 2020 Aug 17, 2020	BUY	$14.35 - $26.64 $3.05 Million - $5.67 Million	212,720 Added 1371.41%	228,231 $5.86 Million
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $3,865 - $10,399	-314 Reduced 1.98%	15,511 $239,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $114,889 - $609,104	15,825 New	15,825 $543,000
Q4 2017 Feb 15, 2018	SELL	$14.27 - $16.79 $567,660 - $667,906	-39,780 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $428,430 - $879,138	39,780	39,780 $628,000

Others Institutions Holding ITCI

# of Institutions

416

Shares Held

88.5M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Intra Cellular Therapies, Inc. Transaction History